Equities research analysts expect Castlight Health Inc (NYSE:CSLT) to report earnings of ($0.15) per share for the current quarter, according to Zacks. Three analysts have made estimates for Castlight Health’s earnings. Castlight Health posted earnings per share of ($0.16) during the same quarter last year, which indicates a positive year-over-year growth rate of 6.3%. The business is expected to issue its next quarterly earnings results on Monday, August 14th.
On average, analysts expect that Castlight Health will report full-year earnings of ($0.47) per share for the current year, with EPS estimates ranging from ($0.48) to ($0.45). For the next financial year, analysts expect that the company will report earnings of ($0.34) per share, with EPS estimates ranging from ($0.40) to ($0.30). Zacks Investment Research’s earnings per share calculations are an average based on a survey of sell-side analysts that that provide coverage for Castlight Health.
Castlight Health (NYSE:CSLT) last issued its earnings results on Wednesday, April 26th. The software maker reported ($0.05) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.05). The firm earned $27.70 million during the quarter, compared to analyst estimates of $28.40 million. Castlight Health had a negative net margin of 73.57% and a negative return on equity of 58.57%. The company’s quarterly revenue was up 22.0% on a year-over-year basis. During the same quarter last year, the business earned ($0.13) earnings per share.
A number of research analysts recently issued reports on CSLT shares. Zacks Investment Research upgraded Castlight Health from a “hold” rating to a “buy” rating and set a $4.25 price objective for the company in a research note on Wednesday, February 22nd. Canaccord Genuity reiterated a “hold” rating and set a $5.00 price objective on shares of Castlight Health in a research note on Friday, January 27th. Cantor Fitzgerald reiterated a “hold” rating and set a $4.50 price objective on shares of Castlight Health in a research note on Thursday, February 23rd. Finally, Cowen and Company started coverage on Castlight Health in a research note on Monday, January 30th. They set a “market perform” rating and a $4.00 price objective for the company. One analyst has rated the stock with a sell rating and seven have assigned a hold rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $4.29.
Shares of Castlight Health (NYSE:CSLT) traded up 1.39% during trading on Monday, reaching $3.65. 569,322 shares of the company’s stock were exchanged. Castlight Health has a 12 month low of $3.05 and a 12 month high of $5.50. The stock has a 50-day moving average price of $3.73 and a 200 day moving average price of $4.00. The firm’s market cap is $383.01 million.
In other Castlight Health news, CEO Giovanni M. Colella sold 34,961 shares of the company’s stock in a transaction that occurred on Friday, February 17th. The stock was sold at an average price of $3.70, for a total value of $129,355.70. Following the completion of the transaction, the chief executive officer now directly owns 37,617 shares in the company, valued at approximately $139,182.90. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CRO John Mccracken sold 14,759 shares of the company’s stock in a transaction that occurred on Tuesday, February 21st. The stock was sold at an average price of $3.62, for a total value of $53,427.58. Following the completion of the transaction, the executive now owns 31,250 shares of the company’s stock, valued at $113,125. The disclosure for this sale can be found here. Insiders sold a total of 93,200 shares of company stock valued at $342,100 over the last 90 days. 37.43% of the stock is currently owned by corporate insiders.
A number of hedge funds and other institutional investors have recently bought and sold shares of CSLT. Teachers Advisors LLC increased its position in Castlight Health by 8.1% in the fourth quarter. Teachers Advisors LLC now owns 62,781 shares of the software maker’s stock valued at $311,000 after buying an additional 4,717 shares during the last quarter. Teza Capital Management LLC acquired a new position in Castlight Health during the fourth quarter valued at $116,000. Edge Wealth Management LLC acquired a new position in Castlight Health during the first quarter valued at $172,000. Royce & Associates LP increased its position in Castlight Health by 53.7% in the fourth quarter. Royce & Associates LP now owns 134,521 shares of the software maker’s stock valued at $666,000 after buying an additional 47,001 shares during the last quarter. Finally, State Street Corp increased its position in Castlight Health by 11.3% in the fourth quarter. State Street Corp now owns 663,065 shares of the software maker’s stock valued at $3,277,000 after buying an additional 67,459 shares during the last quarter. Institutional investors and hedge funds own 51.03% of the company’s stock.
Castlight Health Company Profile
Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.
Get a free copy of the Zacks research report on Castlight Health (CSLT)
For more information about research offerings from Zacks Investment Research, visit Zacks.com